TY - JOUR
T1 - Post-ischemic treatment with Toki-shakuyaku-san (Tang-Gui-Shao-Yao-San) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats
AU - Pu, Fengling
AU - Mishima, Kenichi
AU - Egashira, Nobuaki
AU - Akiyoshi, Yuki
AU - Liu, An xin
AU - Sano, Kazunori
AU - Irie, Keiichi
AU - Ishibashi, Daisuke
AU - Hatip-Al-Khatib, Izzettin
AU - Iwasaki, Kiyo
AU - Kurauchi, Kouji
AU - Iwasaki, Katsunori
AU - Fujiwara, Michihiro
PY - 2005/7/13
Y1 - 2005/7/13
N2 - Previously we have reported that Toki-shakuyaku-san (TSS) ameliorated the impairment of spatial memory induced by single cerebral ischemia (1 × 10 minutes) and scopolamine, a muscarinic receptor antagonist. In this experiment, we studied the effect of TSS on repeated cerebral ischemia (2 × 10 minutes, 1-hour interval) induced impairment of spatial memory and neuronal injury in rats. The 8-day post-ischemic treatment with TSS (30-300 mg/kg) was administered p.o. once per day. TSS dose-dependently prevented the impairment of spatial memory, neuronal death and TUNEL positive cells induced by repeated cerebral ischemia. In order to determine the mechanism of TSS, we also studied the effect of TSS on GluR2 mRNA, one of the glutamate α-amino-3- hydroxy-5-methyl-4-isoxazole (AMPA) receptor subunits. Repeated cerebral ischemia significantly decreased GluR2 flop mRNA at 1 and 3 days after the occlusion. TSS (300 mg/kg) significantly suppressed the decrease in GluR2 flop at 3 days after repeated cerebral ischemia. These results suggested that the TSS has neuroprotective action which may be indirectly mediated by the AMPA receptor, and TSS may be beneficial for the treatment of cerebrovascular dementia.
AB - Previously we have reported that Toki-shakuyaku-san (TSS) ameliorated the impairment of spatial memory induced by single cerebral ischemia (1 × 10 minutes) and scopolamine, a muscarinic receptor antagonist. In this experiment, we studied the effect of TSS on repeated cerebral ischemia (2 × 10 minutes, 1-hour interval) induced impairment of spatial memory and neuronal injury in rats. The 8-day post-ischemic treatment with TSS (30-300 mg/kg) was administered p.o. once per day. TSS dose-dependently prevented the impairment of spatial memory, neuronal death and TUNEL positive cells induced by repeated cerebral ischemia. In order to determine the mechanism of TSS, we also studied the effect of TSS on GluR2 mRNA, one of the glutamate α-amino-3- hydroxy-5-methyl-4-isoxazole (AMPA) receptor subunits. Repeated cerebral ischemia significantly decreased GluR2 flop mRNA at 1 and 3 days after the occlusion. TSS (300 mg/kg) significantly suppressed the decrease in GluR2 flop at 3 days after repeated cerebral ischemia. These results suggested that the TSS has neuroprotective action which may be indirectly mediated by the AMPA receptor, and TSS may be beneficial for the treatment of cerebrovascular dementia.
UR - http://www.scopus.com/inward/record.url?scp=21344450766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21344450766&partnerID=8YFLogxK
U2 - 10.1142/S0192415X05003077
DO - 10.1142/S0192415X05003077
M3 - Article
C2 - 16047564
AN - SCOPUS:21344450766
VL - 33
SP - 475
EP - 489
JO - Comparative Medicine East and West
JF - Comparative Medicine East and West
SN - 0192-415X
IS - 3
ER -